Related Experiment Video
Updated: Jul 8, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Fetal growth and childhood cholesterol levels in the United States
Cynthia L Ogden1, Kenneth C Schoendorf, John L Kiely
1National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD 20782, USA. cogden@cdc.gov
Insights
Infants born small-for-gestational age (SGA) may have a higher risk of elevated cholesterol in early childhood. This study found a potential association, though not statistically significant, between reduced fetal growth and cholesterol levels.
Area of Science:
- Pediatrics
- Public Health
- Endocrinology
Background:
- Fetal development significantly influences long-term health outcomes.
- Small-for-gestational age (SGA) birth is a marker of altered fetal growth.
- Early childhood cholesterol levels are critical indicators of future cardiovascular health.
Purpose of the Study:
- To investigate the association between being born small-for-gestational age (SGA) and the risk of high cholesterol in early childhood.
- To determine if reduced fetal growth predicts elevated serum total cholesterol levels in children aged 4-6 years.
Main Methods:
- Analysis of data from 1727 children (ages 4-6) from the third US National Health and Nutrition Examination Survey.
- Utilized birth certificate data and blood cholesterol measurements.
- Employed logistic regression to assess odds of high cholesterol in SGA vs. non-SGA children, controlling for covariates.
Main Results:
- Approximately 11% of children were born SGA.
- SGA children showed a non-significant trend towards higher odds of elevated cholesterol (OR 1.97).
- Gestation-adjusted birthweight showed a non-significant inverse relationship with cholesterol levels.
Conclusions:
- A potential association exists between reduced fetal growth (SGA) and increased cholesterol in early childhood.
- Further research is needed to confirm the statistical significance and clinical implications of this finding.
- Early life growth patterns may impact lipid metabolism and cardiovascular risk later in life.
Abstract:
Research has linked fetal environment to subsequent adult disease. This study examines the extent to which infants born small-for-gestational age (SGA) were at risk for high cholesterol levels in early childhood (ages 4-6 years). Data were obtained from 1727 children aged 4-6 years who participated in the cross-sectional third US National Health and Nutrition Examination Survey and had both birth certificates and blood cholesterol information. The odds of having moderately elevated (170-199 mg/dL) or high (> or =200 mg/dL) serum total cholesterol after being born SGA were determined after controlling for sex, race/ethnicity, education of household head, saturated fat intake, parental history of high cholesterol and overweight status. Approximately 11% of participants were SGA. Proportions of children with moderately elevated and high cholesterol levels were approximately 28 and 8%, respectively. SGA children were almost twice as likely (odds ratio 1.97, 95% confidence interval [0.8, 4.8]) to have high cholesterol vs. low cholesterol than non-SGA children, although the result was not statistically significant. Multiple linear regression demonstrated a similar inverse, non-significant relationship between gestation-adjusted birthweight and cholesterol (beta = -2.3, P = 0.33). These data indicate a possible association between reduced fetal growth, represented by birthweight adjusted for gestational age, and increased cholesterol levels in early childhood.
Related Concept Videos
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Nature and Nurture
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
